Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pembrolizumab 200 / Bevacizumab 15, Cervical Cancer, Cycle 7+

Protocol-ID: 2251 V1.1 (Mini), PEMB200/BEVA15, Cervical Ca, C7+

Indication(s)

  • Cervical Cancer; ICD-10 C53.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 03.02.2023